HALOGEN COMPOUNDS HAVING THROMBOPOIETIN RECEPTOR AGONISM

摘要

Compounds represented by the following general formula (III), prodrugs thereof, pharmaceutically acceptable salts thereof or solvates of the same which have a thrombopoietin agonism: (III) wherein R<9> represents hydrogen, optionally substituted lower alkyl, etc.; R<10>, R<11> and R<12> independently represent each optionally substituted alkyl, halogeno, etc.; R<14>s independently represent each lower alkyl, halogeno, etc.; n is an integer of 0 to 2; and the ring A<3> is a group represented by the following formula: (wherein R<13> represents hydrogen or lower alkyl; and T represents oxygen or sulfur).